The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 5380 participants.
Also called NCT04028544
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 5,380 participants
- Registry
-
NCT04028544
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04028544. Randomized; quadruple masking; primary purpose treatment. Start 2019-03-26 (actual); primary completion 2020-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients
- Condition
- Heart Failure
- Intervention (Drug)
- Qishenyiqi dropping pills
- Intervention (Drug)
- Placebo
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Tianjin Tasly Pharmaceutical Co., Ltd
Record details
- Record id
cardio:ct-nct04028544- Content hash
a86e4379eaa2235f248c0f38f2af16c2d310ae102a6660dcf442bca297d57c47